{"title":"妊娠期疟疾","authors":"S. Rulisa","doi":"10.1017/9781108684729.144","DOIUrl":null,"url":null,"abstract":"Regardless of symptoms, the presence of plasmodial parasites in a pregnant woman's body will have a negative impact on her own health and that or her fetus. Restricting treatment to symptomatic pregnant women is an inadequate strategy to reduce the morbidity and mortality associated with malaria. [1]Subclinical infection is common in areas where natural immunity is high (eg, sub-Saharan Africa), whereas symptomatic cases are more common in areas with low immunity (eg, the Asia-Pacific region, and South Africa). [2]","PeriodicalId":373558,"journal":{"name":"Analgesia, Anaesthesia and Pregnancy","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Malaria in pregnancy\",\"authors\":\"S. Rulisa\",\"doi\":\"10.1017/9781108684729.144\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Regardless of symptoms, the presence of plasmodial parasites in a pregnant woman's body will have a negative impact on her own health and that or her fetus. Restricting treatment to symptomatic pregnant women is an inadequate strategy to reduce the morbidity and mortality associated with malaria. [1]Subclinical infection is common in areas where natural immunity is high (eg, sub-Saharan Africa), whereas symptomatic cases are more common in areas with low immunity (eg, the Asia-Pacific region, and South Africa). [2]\",\"PeriodicalId\":373558,\"journal\":{\"name\":\"Analgesia, Anaesthesia and Pregnancy\",\"volume\":\"6 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Analgesia, Anaesthesia and Pregnancy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1017/9781108684729.144\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Analgesia, Anaesthesia and Pregnancy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/9781108684729.144","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Regardless of symptoms, the presence of plasmodial parasites in a pregnant woman's body will have a negative impact on her own health and that or her fetus. Restricting treatment to symptomatic pregnant women is an inadequate strategy to reduce the morbidity and mortality associated with malaria. [1]Subclinical infection is common in areas where natural immunity is high (eg, sub-Saharan Africa), whereas symptomatic cases are more common in areas with low immunity (eg, the Asia-Pacific region, and South Africa). [2]